France

Eight in ten respondents in France recognise the need to adapt their lifestyle due to the effects of climate change, according to the annual Climate Survey commissioned by the European Investment Bank (EIB). Among the challenges facing their countries, respondents ranked climate change second only to the cost of living. Many believe that investing in adaptation now will prevent higher costs in the future.

The EIB Group – comprising the European Investment Bank (EIB) and the European Investment Fund (EIF) – and Groupe BPCE recently signed two financing initiatives totalling over €1 billion to back innovation, research and energy transition projects led by small businesses and mid-caps.

The European investment bank (EIB) and Fabentech, a leading French biopharmaceutical company specializing in the development and production of therapeutics against biological threats, have signed a €20 million financing under the HERA Invest mechanism. This €100 million initiative is part of the European Health Union and aims at supporting health emergency prevention and preparedness in Europe, particularly in response to deliberate or natural emergence of biological threats. This significant financing is the result of a thorough analysis of the project’ soundness and is a recognition of the quality of Fabentech’s product portfolio to improve the preparation of Europe against biological threats.